Citation
Zimmerman, R. M. E. (2011, December 21). Apoptin : oncogenic transformation & tumor- selective apoptosis. BOXPress, Oisterwijk. Retrieved from
https://hdl.handle.net/1887/18268
Version: Corrected Publisher’s Version
License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden
Downloaded from: https://hdl.handle.net/1887/18268
Note: To cite this publication please use the final published version (if applicable).
Chapter 6
PP2A inactivation is a crucial step in triggering apoptin- induced tumor-selective cell killing
Rhyenne Zimmerman
1,*, Dongjun Peng
1,2,*, Henriette Lanz
1, Ying-Hui Zhang
1, Astrid Danen-Van Oorschot
1, Shen Qu
2, Claude Backendorf
1and Mathieu Noteborn
1,2,¶1
Department of Molecular Genetics
,Leiden Institute for Chemistry, Leiden University, Leiden, The Netherlands,
2Department of Biochemistry and Molecular Biology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¶
Corresponding author: M.H.M. Noteborn, Department of Molecular Genetics, Graduate School of Chemistry, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands. Tel: +31 71 5274544; Fax: +31 71 5274430; E-mail: m.noteborn@chem.leidenuniv.nl
* contributed equally to the manuscript
Keywords: apoptin, apoptosis, BCA3/AKIP1, PP2A, PKA, SV40 LT and ST
Abbreviations: apoptin, apoptosis inducing protein; AKIP1, A-kinase interacting protein; BCA3, breast cancer-associated gene 3; DAPI, 2,4- diamidino-2-phenylindole; NLS, nuclear localization signal; PKA, protein kinase A; PP2A, protein phosphatase 2A; Rb, Retinoblastoma protein; RNAi, RNA interference; RSV, Rous sarcoma virus; SV40 LT, SV40 large T antigen;
SV40 ST, SV40 small t antigen
Submitted for publication
Abstract
Apoptin harbors tumor-selective characteristics, making it a potentially safe and effective anticancer agent. Apoptin becomes phosphorylated and induces apoptosis in a large panel of human tumor but not normal cell lines. Here, we explored minimal cellular factors required for the activation of apoptin.
Flag-apoptin was introduced into normal fibroblasts together with the
transforming SV40 LT and ST antigens. We found that expression of
nuclearly located SV40 ST in normal cells was sufficient to induce
phosphorylation of apoptin. Mutational analysis showed that C103S
mutation within the protein phosphatase 2A (PP2A)-binding domain of ST
counteracted this effect. Knock-down of the ST-interacting PP2A B56γ
subunit in normal fibroblasts mimicked the effect of nuclear ST expression,
resulting in induction of apoptin phosphorylation. The same effect was
observed upon down-regulation of the PP2A B56δ subunit, which is targeted
by PKA. Apoptin interacts with the PKA-associating protein BCA3 (AKIP1),
and inhibition of PKA in tumor cells by treatment with H89 increased the
phosphorylation of apoptin, whereas the PKA activator cAMP partially
reduced it. We therefore conclude that inactivation of PP2A, particularly of
the B56γ and B56δ subunits, is a crucial step in triggering apoptin-induced
tumor-selective cell death.
Introduction
Tumor formation occurs due to a complicated set of processes roughly based on enhanced survival and limited cell death activities (Wenner, 2010).
Remarkably, a set of viral and cellular proteins has been found to selectively induce cell death in tumor cells (Bruno, et al., 2009). Among these proteins is the avian virus protein apoptin, which has been shown to induce p53- independent apoptosis in a broad spectrum of human transformed cells (Backendorf, et al., 2008). Recent preclinical studies demonstrated the therapeutic potential of apoptin as a safe and efficient anticancer agent (Grimm and Noteborn, 2010). Therefore, it is of interest to study the mechanisms underlying apoptin-induced apoptosis, particularly the ‘switch’
responsible for its activation during oncogenic transformation.
SV40 T antigens are known to be involved in oncogenic transformation through interference with many cellular processes (Pipas, 2009). Distinct domains on LT that bind and inactivate tumor suppressors p53 and Rb, have long been known to play crucial roles in tumor formation (Eichhorn, et al., 2009). The SV40 ST protein enforces transformation of normal cells via negative effects on the protein phosphatase 2A (Sablina, et al., 2010).
This feature is in accordance with the reduced PP2A levels found in various human tumor cell types (Sablina and Hahn, 2008), and accumulating evidence supporting major tumor suppressive roles for PP2A (Westermarck and Hahn, 2008). Another major cellular regulator implicated in carcinogenesis is protein kinase A (PKA) (Naviglio, et al., 2009). Its targets include PP2A (Usui, et al., 1998), and for instance, the PKA interacting protein Breast Cancer-associated gene 3 (BCA3) is known to be highly expressed in breast and prostate cancer cells compared to the normal surrounding tissue (Kitching, et al., 2003).
In this study, we investigated the minimal steps leading to the activation of
apoptin upon malignant transformation. We previously showed that
transient expression of the SV40 large and small T antigens in normal human fibroblasts results in activation of apoptin, displaying all three of its characteristic features, namely phosphorylation, nuclear localization, and apoptosis (Zhang, et al., 2004). Here, we analyzed which domains of the SV40 large and/or small T antigens were responsible for this activity. In parallel, BCA3 was identified as an apoptin-interacting protein, and the effects of PKA on apoptin phosphorylation were examined. Analysis of both transformation-related pathways revealed that inactivation of PP2A is crucial for the activation of apoptin.
Materials and Methods
Cells and Cell culture
Human diploid foreskin F9 fibroblasts, isolated from neonatal foreskin, were obtained in the late 1980’s from Dr. M. Ponec (Dept. Dermatology, Leiden University Medical Center). Cells were batch-frozen after careful morphological inspection. At subsequent passages cells were regularly screened for their typical fibroblast-like morphological appearance. All cells used were below passage 15 and cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 10% newborn calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin (Invitrogen, Breda, the Netherlands). The human Saos-2 osteosarcoma and the HeLa cervical carcinoma cell lines were purchased from the American Type Culture Collection (ATCC) and cultured in the same medium as mentioned above. Cultures were regularly tested to ensure the absence of Mycoplasma infection. Cell morphology was regularly monitored to control the absence of cross-contamination. The sensitivity to apoptin is characteristic of the various cell types used (Danen-van Oorschot, et al., 1997) and is regularly assessed (see below).
DNA plasmids
The DNA sequence encoding apoptin was synthesized by BaseClear (Leiden,
the Netherlands) according to the apoptin sequence published by Noteborn
et al. (1991), and cloned into the mammalian expression vector pcDNA3.1(+)
(Invitrogen). The oligonucleotide fragment encoding the Flag-tag (Invitrogen) was inserted to create the pcDNA-Flag-apoptin plasmid encoding apoptin fused with a Flag-tag at its N-terminus.
Plasmid pRSV-TN136 encoding the first 136 N-terminal amino acids of SV40 LT, including the region coding for SV40 ST, was a kind gift from Dr. J.M.
Pipas (Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA, USA). From pRSV-TN136, we generated the pcDNA- LT136/ST plasmid, which encodes the LT136 (The N-terminally truncated LT fragment containing the first 1-136 aa) and full length ST. pcDNA-LT136, encoding LT136 only, was constructed by introducing an intron deletion disabling ST expression (Yamashita, et al., 1990). pcDNA expression vectors encoding only ST sequences were derived from pRSV-ST. pcDNA-ST encodes for ST; pcDNA-NLS-ST contains a ST fused to a nuclear localization signal (NLS-ST) and pcDNA-NLS-ST(C103S) encodes the N-terminal NLS-ST fusion protein containing the C103S mutation within the PP2A binding site (Gjoerup, et al., 2001).
The sequences encoding the N-terminal 136 aa of LT together with either full-length ST or the C103S ST-mutant were cloned into pEXPR-IBA105 vector to generate pEXPR-IBA105-LT136/ST and pEXPR-IBA105- LT136/STC103S respectively. These plasmids expressed Strep-tagged LT136/ST or LT136/ST C103S proteins enabling interaction studies with PP2A (see below) (Schmidt and Skerra, 2007). pCEP-4HA-B56γ, encoding 4HA-tagged B56γ, was a kind gift from Dr. M. Mumby (University of Texas, USA).
Apoptin-interacting partners were obtained by yeast two-hybrid screening
and verified by immunoprecipitation assays in mammalian cells, as
previously described by Danen-Van Oorschot et al. (Danen-van Oorschot, et
al., 2004). Positive clones from the yeast two-hybrid screen were digested
with Xho-I to generate cDNA fragments, and subcloned into pMT2SM-myc to
provide the fragments with an in-frame N-terminal myc-tag. The cDNA
fragment encoding BCA3, including the myc-tag, was subsequently cloned into pcDNA.
Transfection Methods
We used transfection reagent DOTAP (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N- trimethylammonium methylsulfate) (Danen-van Oorschot, et al., 1997) or AMAXA nucleofection technology in conjunction with cell type specific NucleofectorTM solution (Lonza, Cologne, Germany) (Rohn, et al., 2002) for DNA delivery into cells. When co-transfection or triple-transfection was performed, the ratio of each plasmid was 1:1 or 1:1:1 (in micrograms). In addition to the analysis by Western blot, the cells were seeded on several glass cover slips to allow parallel analysis at the single-cell level by immunofluorescence assay.
Western Blot analysis
Cells were lysed directly in Laemmli buffer (2% SDS, 10% Glycerol, 60mM
Tris-Cl [pH6.8], 2% β-mercaptoethanol, 0.002% bromophenol blue). Cell
lysates were separated by sodium dodecyl-sulfate-polyacrylamide gel
electrophoresis, and electroblotted onto polyvinylidene difluoride membranes
(Bio-Rad). Blots were then incubated with antibodies against
phosphorylated-apoptin (α-108-P; Zhang, et al., 2004), Flag-apoptin (α-Flag
M2, Sigma-Aldrich), SV40 LT (PAb416, Pab419, Calbiochem), SV40 ST
(Pab280, Calbiochem), PP2A Aα (C-20, Santa Cruz), PP2A B56γ (α-B56γ, kind
gift from Dr. Marc Mumby, Health Science Center, University of Texas,
Texas, USA), PP2A B56δ (α-B56δ, Santa Cruz Biotechnology), myc-tagged
BCA3 (α-myc, BD Biosciences), and actin (α-actin, Santa Cruz). Horseradish
peroxidase-conjugated goat antibody against rabbit or mouse
immunoglobulin G, or rabbit antibody against goat immunoglobulin G
(Sigma-Aldrich) was used as secondary antibody for signal detection by
enhanced chemiluminescence.
Protein interaction assays
Detection of a possible interaction of ST or ST-C103S mutant protein with PP2A in human HeLa cells was performed as follows. Twenty-four hours after DNA transfection, cells were washed twice with phosphate buffered saline and harvested in ice-cold mild lysis buffer (50mM Tris [pH 7.5], 5mM EDTA, 250mM NaCl, 0.1% Triton X-100, 5 mM NaF, 1mM Na
3VO
4, 20mM beta-glycerolphosphate, and Protease Inhibitor Cocktail (Roche), followed by incubation on ice for 30 min. The supernatant of the lysates was prepared by centrifugation at 13,000 × g and 4°C for 30 min. Strep-tagged proteins and their interacting proteins were captured using the One-strep kit (IBA, Germany) according to the manufacturer’s protocol, and resolved on sodium dodecyl sulfate-polyacrylamide gel, followed by Western blotting analysis with appropriate antibodies.
RNA interference assay
For human PP2A B56γ, the target sequence was: 5’- GATGAACCAACGTTAGAAG-3’; for PP2A B56δ two sequences were targeted (1): 5’ GTGTGTCTCTAGCCCCCAT 3’ (Arnold, et al., 2006) and (2) 5’
GACCATTTTGCATCGCATC 3’ (van Kanegan and Strack 2009) (data not shown). The pSUPER vector was designated for shRNA plasmid constructions (Boutros and Ahringer, 2008). The amplification and purification of plasmids were performed as specified by manufacturer’s instruction (GeneService, Cambridge, UK). Cells transfected with shRNA plasmids were lysed at 24-48 h after transfection, and then analyzed by Western blot assay as described above.
Immunofluorescence assay
Cells were grown on glass cover slips. At indicated time points after transfection, cover slips were first washed once with phosphate buffered saline, and subsequently fixed with methanol/acetone (50%/50%) for 5-10 min at room temperature. After air-drying, the slides were used for immunocytochemical staining or stored at -20°C for further analysis.
Immunocytochemical staining was carried out as described by Danen-Van
Oorschot et al. (2004). The following antibodies were used: α-108-P, a rabbit polyclonal antibody recognizing phosphorylated apoptin at T108 and α-Flag, a mouse monoclonal antibody recognizing Flag-apoptin. SV40 proteins were visualized with PAb416, a mouse monoclonal antibody recognizing the epitope residing in amino acids 83-128 of LT and non-reactive with ST or PAb280, a mouse monoclonal antibody against the C terminus of ST. The fluorescein isothiocyanate (FITC) or rhodamine conjugated goat antibodies (Jackson ImmunoResearch Laboratories) were used as secondary antibodies.
Nuclei were stained with 2,4-Diamidino-2-phenylindole (DAPI) and apoptosis was assessed according to characteristic morphological changes (Danen-van Oorschot et al., 1997).
PKA inhibition and stimulation
Saos-2 cells were transfected with pcDNA-Flag-apoptin and incubated 24 hours post-transfection with 10µM H89 (Millipore) for 1 hour (PKA inhibition), or 30 minutes with H89 followed by incubation with 1mM cAMP (Sigma) for another 30 minutes (PKA stimulation). Cells were then lysed in Laemmli buffer and the cell lysates analyzed for apoptin phosphorylation by Western blotting.
Results
Transient expression of N-terminal SV40 LT136/ST activates apoptin in normal human fibroblasts
Apoptin activity can be induced in normal cells by transient expression of transforming SV40 antigens (Zhang, et al., 2004). Here, we examined the minimal SV40 domains responsible for this effect. Expression of the SV40 LT136/ST DNA sequence results, due to alternative splicing, in 2 proteins:
LT136, comprising the N-terminal 136 a.a. of LT, and the entire ST protein,
consisting of 174 amino acids (Figure 6.1A) (Srinivasan, et al., 1997). LT136
contains a DNA J domain, an Rb-binding site and a nuclear localization
signal (NLS). ST shares its DNA J domain with LT136, but has a unique C-
terminal domain encompassing a PP2A binding site (Pipas, 2009).
Figure 6.1 Transient expression of N-terminal determinants of SV40 T antigens activate apoptin. A. Schematic representation of the domains in SV40 LT136/ST. The J domain (a.a.
1-82) is identical in both LT136 and ST. The Rb binding domain and nuclear localization signal (NLS) in LT136 are also shown. ST is expressed by differential splicing and has a unique C-terminus, which contains the PP2A binding domain. B. Human Fibroblasts (F9) were co-transfected with plasmids pcDNA-Flag-apoptin and pcDNA-LT136/ST (LT136/ST) or pcDNA-neo (neo) by AMAXA nucleofector transfection. Twenty-four hours post- transfection, cells were lysed for Western blot analysis with the indicated antibodies. Mock- transfected F9 cells were used as control. Antibody α-108-P specifically recognizes phospho- apoptin at its Thr108. Flag-apoptin, LT and ST show the respective total protein amounts in the transfected cells. Actin was used as loading control. C-E. Cells were fixed for immunofluorescence analysis at each given time point after transfection and then stained with the indicated antibodies by indirect immunofluorescence assay. Scale bar = 20 µm.
In normal human foreskin fibroblasts, co-transfection of the SV40 LT136 and ST proteins with Flag-tagged apoptin resulted in the latter’s phosphorylation (Figure 6.1B). Immunofluorescence analysis of F9 cells expressing all three proteins showed that Flag-apoptin became nuclear already 1 day after transfection. Nuclear Flag-apoptin was also shown to be phosphorylated (Figure 6.1C), and 3 and 5 days post transfection, apoptin was shown to induce apoptosis (Figure 6.1D, E). In contrast, F9 fibroblasts expressing apoptin alone contained mainly cytoplasmic Flag-apoptin, which was, as expected, not phosphorylated (Alvisi, et al., 2006; Rohn, et al., 2004) and did not induce apoptosis (Figure 6.1C-E).
Our results clearly reveal that transient expression of LT136 and ST proteins in human F9 fibroblasts results in tumor-selective activation of apoptin, providing us with the possibility to explore which domains and respective cellular targets of LT136/ST were responsible for this activity.
Nuclearly localized ST triggers apoptin activation
Next, we examined whether expression of either LT136 or ST protein alone
was sufficient to activate apoptin phosphorylation. F9 fibroblasts were co-
transfected with plasmids encoding Flag-tagged apoptin and either one of the
following: a) pcDNA-LT136, encoding LT136, b) pcDNA-ST, encoding ST, c)
pcDNA-LT136/ST, where both LT136 and ST are produced via alternative
splicing, or d) pcDNA-neo, as a negative control. In each experiment,
activation of apoptin was assayed by its phosphorylation at position T108,
assessed by means of Western blotting. Expression of LT136 alone did not
trigger apoptin phosphorylation, whereas expression of ST clearly induced
apoptin phosphorylation, albeit at a low level (Figure 6.2). Co-transfection of
Flag-tagged apoptin with ST fused to an artificial nuclear location signal
(NLS-ST) increased the level of apoptin phosphorylation significantly (Figure
6.3B).
Figure 6.2 Nuclear targeting of SV40 ST activates apoptin. In normal human fibroblasts, apoptin was co-transfected with vector only (Neo), LT136, ST, or both LT136 and ST. Twenty-four hours post-transfection, cells were lysed for Western blot analysis with the antibodies indicated.
C103S mutation within PP2A-binding domain of ST disables activation of apoptin
Besides its J domain, shared with LT136, ST contains a unique site for the binding and inactivation of PP2A. This domain has been shown to contribute to cellular transformation (Pipas, 2009). A single amino-acid mutation C103S within the ST protein drastically diminishes the interaction of ST with PP2A (Figure 6.3A) and its transforming capacity (Fahrbach, et al., 2008).
Therefore, we studied the effect of the C103S mutation within the PP2A binding site on the activation of apoptin by (nuclear) ST in normal human cells.
F9 cells were analyzed for phosphorylation of Flag-apoptin upon co- expression with ST, NLS-ST or NLS-ST(C103S) protein. Figure 6.3B shows that expression of NLS-ST clearly induced apoptin phosphorylation.
Introduction of the NLS-ST(C103S) mutation completely abolished this
induction, although apoptin protein was expressed at a similar level. These
results suggest that ST interaction with PP2A is crucial to apoptin activation,
and that inactivation of PP2A by ST might be sufficient to activate apoptin.
Figure 6.3 Apoptin activation via inhibition of PP2A by ST. A. PP2A binding to ST is abolished by C103S mutation. LT136 and ST with or without the C103S mutation (LT136/ST or LT136/ST(C103S) were fused with a Strep-tag at their N-terminus. Cell lysates were prepared at 24h post-transfection for protein-protein interaction assays as indicated in Material and Methods. The final elutions were analyzed by Western Blot with antibodies against PP2Aα subunit, LT and ST, respectively. Actin was taken as equal loading control. The first lane (input control) indicated total amount of endogenous proteins in direct cell lysates. B. pcDNA-Flag-apoptin was co-transfected with plasmids encoding the indicated proteins or vector DNA into F9 primary fibroblasts. Western blot assays were performed with the indicated antibodies at 24h post-transfection.
Knock-down of PP2A B56γ via RNAi activates apoptin phosphorylation in normal human fibroblasts
Two independent studies reported that ST interaction with PP2A resulted in the inhibition of the B56γ regulatory subunit, resulting in cellular transformation (Chen, et al., 2007; Cho, et al., 2007). Therefore, we examined whether down-regulation of B56γ via RNAi could trigger phosphorylation of apoptin in normal cells. Our shRNA sequence was verified to reduce ectopic expression of B56γ (Figure 6.4A). Normal F9 fibroblasts co-expressing both apoptin and shRNA directed against B56γ mRNA manifested a clear level of phosphorylated apoptin in comparison to the cells transfected with apoptin and the RNAi control vector (Figure 6.4C).
Our data thus indicate that inhibition of the PP2A B56γ subunit is a crucial
and sufficient step for apoptin phosphorylation.
Figure 6.4 Knock-down of PP2A B56γ and B56δ subunits triggers apoptin phosphorylation in normal cells. A. Down-regulation of PP2A B56γ subunit by shRNA. HeLa cells were co- transfected with pCEP-4HA-B56γ expressing 4HA-tagged B56γ, and either shB56γ or control pSuper vector and lysed 48h post-transfection, followed by western blotting analysis with the indicated antibodies. B. Down-regulation of PP2A B56δ subunit by shRNA. F9 cells were transfected with pSuper vector encoding shRNA directed against PP2A B56δ or pSuper vector control; 24h post-transfection, cell lysates were prepared and subsequently analyzed by Western blot. C. F9 cells were co-transfected with Flag-apoptin and either pSuper vector encoding shRNA directed against PP2A B56γ, δ or control; 24-48h post-transfection, cell lysates were prepared and subsequently analyzed by Western blot.
Over-expression of PKA-interacting protein BCA3 stimulates apoptin activity in tumor cells
Analogous to the enhancing effect of ST on apoptin phosphorylation in normal cells, we observed an enhancement of apoptin phosphorylation in tumor cells by BCA3. BCA3 was identified as an apoptin-interacting protein by means of a yeast two-hybrid assay, and interacts with apoptin in a human cellular background (Figure 6.5A). Co-expression of BCA3 and Flag- apoptin in human Saos-2 tumor cells resulted in a significant increase in the apoptosis activity of apoptin (Figure 6.5B). In fact, as early as 6 hours after transfection, phosphorylated apoptin could readily be detected in Saos-2 cells expressing both apoptin and BCA3, whereas in cells expressing apoptin alone (control), apoptin phosphorylation was not yet visible at this early time-point (Figure 6.5C).
As BCA3 (9) has been shown to interact with the catalytic subunit of PKA
(Sastri, et al., 2005), the involvement of PKA in apoptin phosphorylation was
investigated. Treatment of Saos-2 cells with H89, a known PKA inhibitor
(Lochner and Moolman, 2006), enhanced apoptin phosphorylation. In
contrast, addition of the PKA activator cAMP (Bulun and Simpson, 2008) diminished apoptin phosphorylation (Figure 6.5D). These results suggest that interference with PKA activity favors activation of apoptin. Taking into account the fact that PP2A has been shown to be a target of PKA (Ahn, et al., 2007), this provides another link pointing to the involvement of PP2A in the activation of apoptin.
Figure 6.5 BCA3 interacts with apoptin and stimulates its activity.
A. Apoptin interacts with BCA3 in a cellular background. Normal human foreskin fibroblasts were transfected with plasmids encoding myc-tagged BCA3 and Flag-tagged apoptin, or control plasmid in the indicated combinations. Total lysates (L) or
protein complexes immunoprecipitated (IP) with
antibody against the myc- (left panel) or Flag-tags (right panel) were separated by SDS-PAGE and analyzed by Western blot. B.
Expression of myc-BCA3 together with Flag-apoptin results in increased induction of apoptosis.
Human Saos-2 tumor cells were transfected with plasmids encoding Flag-tagged apoptin and myc-tagged BCA3, or vector control in the indicated combinations and grown on glass coverslips. Forty-eight hours post-transfection, slides were fixed and stained with appropriate antibodies for immunofluorescence analysis (right panel). pMaxGFP (Amaxa) was used as a negative control for apoptosis. Data are representative of 3 independent experiments, in which at least 100 cells were scored. C. Co-expression of myc-BCA3 enhances apoptin phosphorylation. Saos-2 cells transfected with BCA3 and apoptin, or apoptin alone, were lysed 6 hours post-transfection and analyzed for apoptin phoshphorylation by Western blot analysis. D.
Inhibition of PKA results in increased apoptin phosphorylation. Saos-2 cells were transfected with Flag-tagged apoptin, and treated with the PKA inhibitor H89 (1h, 10µM) or activator cAMP (30 minutes, 10µM H89, followed by 30 minutes 1mM cAMP) 24hs post- transfection. Cells were then lysed and their contents analyzed by Western blot using indicated antibodies.